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Abstract
Purpose—The purpose of this study is to compare health behaviors and cancer screening among 
Californians with and without a family history of cancer.
Methods—We analyzed data from the 2005 California Health Interview Survey to ascertain 
cancer screening test use and to estimate the prevalence of health behaviors that may reduce the 
risk of cancer. We used logistic regression to control for demographic factors and health care 
access.
Results—Women with a family history of breast or ovarian cancer were more likely to be up-to-
date with mammography compared to women with no family history of cancer (OR = 1.69, 95% 
CI [1.39, 2.04]); their health behaviors were similar to other women. Men and women with a 
family history of colorectal cancer were more likely to be up-to-date with CRC screening 
compared to individuals with no family history of cancer (OR=2.77, 95% CI [2.20, 3.49]), but 
were less likely to have a BMI < 25 kg/m2 (OR=0.80, 95% CI [0.67, 0.94]).
Conclusion—Innovative methods are needed to encourage those with a moderate to strong 
familial risk for breast cancer and colorectal cancer to increase their physical activity levels, strive 
to maintain a healthy weight, quit smoking, and reduce alcohol use.
Keywords
family medical history; behavioral risk factors; colorectal neoplasms; breast neoplasms; cancer 
screening
INTRODUCTION
Hereditary breast and ovarian cancer (HBOC) syndrome and Lynch syndrome increase 
individual risk for breast, ovarian, colorectal (CRC), and uterine cancers.1 Inherited 
mutations associated with these syndromes account for up to 10% of each of these cancers in 
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the United States.1 In addition to these genetic syndromes, family medical history (FMH) is 
an established risk factor for blood relatives to develop the same or related cancers. Along 
with shared genetic risk factors, families may also share the same environment and 
exposures, and similar health behaviors which lead to increased cancer risk.
Nearly 8% of people in the United States report having a first-degree relative with a history 
of breast cancer; 7.1%, with a history of lung cancer; 5.0%, with a history of CRC; 4.7%, 
with a history of prostate cancer; and 1.8%, with a history of ovarian cancer.2 Having a first-
degree relative with breast cancer increases an individual’s risk two-fold.3 Similarly, having 
a first-degree relative diagnosed with CRC doubles a person’s risk.4 Convincing evidence 
demonstrates that alcohol consumption increases risk for both pre- and postmenopausal 
breast cancers5 and CRC.6 Obesity increases risk for endometrial,7 CRC,6 and 
postmenopausal breast cancer.5 Regular physical activity is associated with a lower risk of 
colon cancer,8 and likely reduces risk for endometrial cancer7 and breast cancer in 
postmenopausal women.5 Tobacco use can increase risk for CRC,9 and may modestly 
increase breast cancer risk based on findings from recent large prospective cohort studies.10 
Fruit and vegetable consumption 5,11 and dietary intake of fat5 likely have little effect on 
breast cancer risk. Although fruit and vegetable consumption has not been consistently 
linked with CRC,11 consumption of red and processed meat may increase risk, while high 
fiber diets may lower risk.6 Approximately 23% of CRC cases could be prevented through 
the combination of no smoking, regular physical activity, limiting alcohol use, and 
maintaining a healthy diet and waist circumference. 12
Modification of dietary and lifestyle behaviors can reduce the risk of breast and CRC even 
in individuals with FMH of these cancers.13,14 While cancer screening test use is higher in 
persons with FMH of CRC15,16 and breast cancer16; less is known about their health 
behaviors at the population-level.17 Additionally, few studies have addressed how FMH can 
be used to motivate individuals to adopt and maintain healthy lifestyles to reduce disease 
risk.18
The aim of this study is to examine health behaviors (maintenance of healthy weight, 
prudent alcohol use, regular physical activity, fruit and vegetable consumption, and no 
smoking) of Californians who report having one or more family members with a history of 
cancer (primarily in first-degree relatives), compared with health behaviors of individuals 
who report no FMH of cancer in a first-degree relative, with emphasis on family history of 
breast or ovarian cancers, CRCs, and FMH of early onset cancer in a first-degree relative. 
CRC and breast cancer screening test use is also compared among these individuals. We 




Adult and family health history public use data files of the 2005 CHIS (the most current data 
at the time this study was conducted) were obtained. CHIS is a population-based, random-
digit-dialed telephone survey conducted every 2 years with non-institutionalized California 
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resident households, to obtain information on health behaviors, health care access, insurance 
coverage, health status, and a variety of other health-related topics. The CHIS uses a two-
stage geographically stratified sampling design and interviews are conducted in five 
languages to reach California’s diverse population. More information on CHIS methodology 
can be obtained at http://www.chis.ucla.edu/designs-methods.html. In 2005, over 45,000 
households participated in the CHIS with an overall household response rate of 29.5%. This 
response rate is based on the American Association for Public Opinion Research 
(AAPOR)’s overall response rate definition, which includes partially completed 
questionnaires (http://www.chis.ucla.edu/pdf/CHIS2005_method4.pdf).
In the 2005 CHIS adult survey, Californians aged 18–64 years were asked about their FMH 
of any cancer among first-degree (mother, father, brother(s), sister(s), and children) and 
second-degree (grandparents, aunts, and uncles) relatives. Distinctions were made between 
half and full siblings. For each affected family member, respondents were asked about the 
specific type of cancer (breast, ovarian, uterine/endometrial, or colon/ rectum for female 
family members, and breast, colon/rectum, or prostate cancer for male family members) and 
if the affected family member was under age 50 years at the time of his or her diagnosis.
Inclusion Criteria
The adult CHIS public-use dataset included 43,020 adults. We excluded 9,833 adults aged ≥ 
65 years because they were not asked their FMH of cancer. We excluded an additional 2,501 
respondents because they had a personal history of any cancer, and 426 additional 
respondents who did not know if they had a first-degree family member with a history of 
cancer. This left 30,260 respondents for the analysis.
We created indicator variables (Table 1) based on responses to the FMH module regarding 
type of cancer and the affected family member to classify respondents who would be at 
moderate to strong risk for cancer based on their FMH profile (degree of relation, number, 
age of affected relatives): 1) Any family history of cancer (primarily in a first-degree 
relative); or 2) FMH of CRC; 3) FMH of breast or ovarian cancer; and 4) FMH history of 
CRC, breast, prostate, ovarian, or endometrial cancer in a first-degree relative diagnosed 
under age 50 (i.e. early onset), which included examining the subpopulations of FMH of 
CRC and breast or ovarian cancer separately in descriptive analyses only. We included 
ovarian cancer history and second-degree relatives in the same lineage to better classify 
women at moderate-to-strong risk for developing familial breast cancer.19 Of 18,501 
respondents with no FMH of cancer in a first-degree relative, 251 women had female breast 
or ovarian cancer in two or more second-degree relatives in the same lineage or a second-
degree male relative with breast cancer, and 83 respondents without a first-degree relative 
diagnosed with cancer had two or more second-degree relatives in the same lineage with 
CRC. These respondents with FMH of breast, ovarian, or CRC were grouped with 
respondents having a first-degree relative with cancer. This left 12,026 respondents with a 
FMH of cancer, and 18,234 without.
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Variables and Statistical Analysis
We examined the following demographic or health care access variables: sex, age group, 
race/ethnicity (based on race/ethnic group respondent most identified with), household 
income, education level, health insurance coverage, marital status, general health condition, 
having a condition that substantially limits one or more basic physical activities, and having 
a usual place to go when sick or in need of health advice. We included the following health 
behaviors: eating five or more servings of fruits and vegetables/ day (marker of a healthy 
diet/ weight management aid),20 regular physical activity (20 minutes of vigorous physical 
activity ≥ 3 days in the past week or 30 minutes of moderate physical activity ≥ 3 days in the 
past week), smoking status (current, former/ never smoked regularly), binge drinking in the 
past month (≥ 5 drinks per occasion for men and ≥ 4 drinks per occasion for women), and 
self-reported body mass index (BMI) (underweight/normal: <25.0 kg/m2, overweight/obese: 
25.0 kg/m2 or higher).
Respondents were considered up-to-date with cancer screening tests if they were screened 
according to 2005 United States Preventive Services Task Force (USPSTF) guidelines. We 
classified respondents aged ≥ 50 years as being up-to-date with CRC screening if at least 
one of the following conditions were met: fecal occult blood test (FOBT) received within 
the past year, sigmoidoscopy within the past 5 years, or colonoscopy within the past 10 
years. Women aged ≥ 40 years were considered up-to-date with screening for breast cancer 
if they had received mammography within the past 2 years. For women who were up-to-date 
with mammography screening, we examined the reason women provided for receiving their 
last mammogram. For men and women aged ≥ 40 years with FMH of CRC, we also 
assessed receipt of colonoscopy within the past 5 years and receipt of any CRC screening 
test within appropriate time intervals for average-risk individuals because more stringent 
screening is recommended in this population.21 Because women with FMH profiles of early 
onset breast or ovarian cancer may be encouraged to initiate breast cancer screening at an 
earlier age than average-risk women,22 we examined the prevalence of women aged ≥ 30 
years receiving a mammogram within the past year.
We used SAS v9.2 (SAS Institute, Cary, NC) and SAS callable SUDAAN release 10 
(Research Triangle Institute, Research Triangle Park, NC) to conduct all analyses to account 
for the complex sampling design of CHIS. In both the descriptive and multivariate logistic 
regression analyses, the jackknife method was used to calculate variance, because replicate 
weights were provided to accurately calculate variance due to the complex sampling design 
of the CHIS. All estimates were weighted to produce population estimates that account for 
the probability of selection and factors associated with survey design and administration 
(e.g., non-response and under-coverage due to lack of a residential landline).
We conducted a descriptive analysis comparing respondents with each of the different FMH 
of cancer profiles to persons without a FMH of cancer, to obtain percentages and standard 
errors on demographic characteristics, health behaviors of interest, and cancer screening test 
use. P values were obtained from Rao-Scott chi-square tests. We conducted a multivariate 
logistic regression analysis, building separate logistic regression models with the following 
seven outcomes as dichotomous variables (yes vs. no): 1) eating five or more servings of 
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fruits and vegetables per day; 2) engaging in regular physical activity; 3) not a current 
smoker; 4) BMI < 25.0 kg/m2; 5) no alcoholic binge drinking in the past month (i.e., the 
month preceding survey), and 6) up-to-date with CRC screening; and 7) breast cancer 
screening. Models were run separately for any FMH of cancer, FMH of breast or ovarian 
cancer (women only), FMH of CRC, and FMH of early onset cancer in a first-degree 
relative to obtain odds ratios and 95% confidence intervals for the outcomes of interest 
adjusted for demographic characteristics and health care access. The referent group in all 
models was respondents without FMH of cancer. We used a backwards elimination 
approach to eliminate nonsignificant (P < 0.05) covariates from all models (with the 
exception of age, race/ethnicity, and having a usual healthcare provider).Covariates initially 
included in the health behavior models were: age, sex (except for the FMH of breast or 
ovarian cancer model), race/ethnicity, household income, health insurance status, education 
level, having a usual health care provider, having a condition that substantially limits one or 
more basic physical activities, marital status, and general health status. Covariates initially 
included in the cancer screening models were: age, race/ethnicity, household income, health 
insurance status, education level, having a usual health care provider, marital status, and sex 
(CRC screening models).
RESULTS
Prevalence of FMH of cancer was higher among women, older age groups, and more 
educated, higher income individuals (Table 2). Non-Latino whites and American Indians/
Alaska Natives (42.8% and 37.5%, respectively) reported a higher prevalence of any FMH 
of cancer, while Asian/Pacific Islanders and Latinos had the lowest prevalence (22.1%, and 
17.6%, respectively; P < 0.0001). Prevalence of FMH of cancer was more often reported by 
individuals with health care coverage and who had a usual health care provider.
Nearly 45% of men and women with FMH of CRC consumed five or more servings of fruits 
and vegetables per day compared to 49.5% of men and women without FMH of cancer 
(Table 3; P =0.0057). After adjustment for demographic characteristics and health care 
access, men and women with FMH of CRC were 16% less likely to consume five or more 
servings of fruits and vegetables per day (OR=0.84, 95% CI [0.73, 0.96]). After adjustment 
for demographic characteristics and health care access in multivariate models, no significant 
differences were found for binge drinking. Men and women with FMH of any cancer had 
lower rates of a BMI < 25.0 kg/m2 compared to men and women with no FMH of cancer 
(42.6% vs. 45.7%, respectively; P =0.0001); results are similar for persons with FMH of 
CRC (39.4%, P =0.0011) and FMH of early onset cancer (41.6%, P =0.0074). After 
adjustment for demographic characteristics and health care access, men and women with 
FMH of any cancer were 9% less likely to report being normal/underweight compared to 
persons without FMH of cancer (OR=0.91, 95% CI [0.85, 0.98]), and men and women with 
FMH of CRC were 20% less likely to report being normal/underweight (OR=0.80; 95% CI 
[0.67, 0.94]).
Among men and women aged ≥ 50 years with FMH of CRC, 71.5% were up-to-date with 
CRC screening, compared to 44.5% of persons without FMH of cancer (P <0.0001). After 
adjustment for demographic characteristics and health care access, men and women with 
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FMH of CRC were nearly 2.8 times more likely to be up-to-date (OR=2.77; 95% CI [2.20, 
3.49]); while persons with FMH of any cancer and persons with FMH of early onset cancer 
were more likely to be up-to-date compared to persons without FMH of cancer (OR=1.33, 
95% CI [1.17, 1.51] and OR=1.37, 95% CI [1.12, 1.66], respectively). Nearly 58% of men 
and women aged 40 – 64 years with FMH of CRC and 53% with FMH of early onset CRC 
were up-to-date at screening intervals recommended for the average-risk population (P 
<0.0001 and P <0.0001, respectively). Among this age group, 42.0% of persons with FMH 
of early onset CRC had received a colonoscopy within the past five years (P <0.0001). 
These findings were nearly identical to all persons with FMH of CRC.
Although women with FMH of breast or ovarian cancer reported higher levels of regular 
physical activity, lower rates of not being a current smoker, and lower rates of normal/
underweight status compared to women without FMH of cancer, these differences for 
physical activity, smoking status, and weight disappeared after adjustment for demographic 
characteristics and health care access (Table 4).
Eighty-five percent of women aged 40 – 64 years with FMH of breast or ovarian cancer had 
received a mammogram within the past two years, compared to 73.7% of women without 
FMH of cancer (P <0.0001). After adjustment for demographic characteristics and health 
care access, women with FMH of breast or ovarian cancer were nearly 1.7 times more likely 
to be up-to-date compared to women without FMH of cancer (OR=1.69, 95% CI [1.39, 
2.04]). Among women aged 30 – 64 years who had received a mammogram within the past 
two years, 33.2% of women with FMH of breast or ovarian cancer and 41.7% with FMH of 
early onset breast or ovarian cancer reported that the reason for the test was due to family 
history, compared to 2.6% of women with no FMH of any cancer (P <0.0001). Younger 
women (aged 30 – 49 years) more frequently reported family history as a reason for the test 
than older women (data not shown). Fifty-six percent of women aged 30 – 64 years with 
FMH of early onset breast or ovarian had received a mammogram within the past year (P 
<0.0001). Rates were highest among women aged 50 – 59 years (78.7%) compared to 
women aged 30 – 39 years and 40 – 49 years (28.4% and 55.5%, respectively; data not 
shown).
DISCUSSION
In this large, population-based study, we found that men and women with an FMH of CRC 
were less likely to maintain a healthy weight and consume 5 or more servings of fruits and 
vegetables per day (which increases risk for CRC), than those without FMH of cancer. 
Conversely, we found that men and women with FMH were more likely to be up-to-date 
with cancer screenings than those without. To our knowledge, these weight-related findings 
are some of the first to be presented for individuals with cancer FMH. Additionally, our 
study, being one of only a few that is population-based, strengthens the literature on all 
health behaviors and cancer screenings in those with FMH of cancer.
While our findings on healthy weight among individuals with FMH of CRC appear to be 
novel, our health behavior findings on physical activity and alcohol use are generally similar 
to those from other recent studies. 17,23 In our study, women with FMH of breast or ovarian 
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cancer had health behaviors similar to women without FMH of cancer. Other studies have 
found similar results,24,25 although some studies have found more intense or higher levels of 
physical activity in women with a family history of breast cancer,26–28 or greater practice of 
health behaviors was observed, compared with the general population.26 In some of these 
studies, data were drawn on women of higher education or socioeconomic status;26,28 
therefore, these findings may not be generalizable to other populations, including ours.
Taken together, our health behavior findings indicate that there may be missed opportunities 
to improve the health of a population that is at increased risk of cancer. FMH of cancer 
represents a complex interaction between genes and environment. Since only a small 
fraction of cancer cases are attributable to hereditary syndromes, clinicians should consider 
health behavior counseling when they encounter patients with FMH of cancer, because they 
may be exhibiting the same negative behaviors that likely contributed to their relative’s 
cancer. Studies have shown that persons with FMH of breast or CRC are more likely to 
receive recommendations from health care providers to improve health behaviors, but the 
overall number receiving these recommendations may be low.17,29 In one study, women 
with FMH of breast cancer were more likely to report making one or more health behavior 
changes because of a recently diagnosed first-degree relative.30 Persons with a FMH of CRC 
may also be willing to make health behavior changes and to follow through,17 but awareness 
of risk factors for CRC may be low.31 Additionally, awareness of FMH of cancer may not 
always translate into positive health behaviors. Conversely, it may place too much emphasis 
on genetic susceptibility.32 In this study, we were unable to assess if our study findings were 
due to a lack of awareness of risk factors for breast and CRC. Regardless, patients with an 
FMH of cancer may benefit from a targeted approach to improving their health behaviors. 
Findings from the Family Healthware Impact trial indicate modest increases in physical 
activity levels after a targeted intervention.33
Results from our cancer screening analysis showed that women with FMH of breast or 
ovarian cancer were nearly 1.7 times more likely to be up-to-date with mammography 
screening compared to women without FMH of cancer, but nearly 15% were not up-to-date 
with recommendations for women at average risk for breast cancer. Although men and 
women with FMH of CRC were 2.8 times more likely to be recently screened compared to 
men and women without FMH of cancer, nearly 29% were not currently up-to-date with 
recommendations for average-risk individuals. Nearly 42% of women with FMH of early 
onset breast or ovarian cancer reported that the reason for their last mammogram was due to 
FMH of cancer. Although sample sizes were small, we found this varied considerably by 
age. Younger women more frequently reported family history as a reason compared to older 
women. Our findings of increased cancer screening test use among Californians with FMH 
of cancer are similar to other studies that examine this. 15,16 These findings indicate that 
many patients and their health care providers recognize the increased risk conferred by FMH 
of cancer. However, screening for CRC is suboptimal for men and women with FMH of 
early onset CRC; 58% had not received a colonoscopy within the past 5 years. While having 
a FMH of cancer did increase the odds of breast and CRC screening, a considerable portion 
of individuals in our study with FMH of early onset CRC, breast or ovarian cancer were not 
appropriately screened considering their FMH profile. Although sample sizes were small, 
only 28% of women aged 30 – 39 years with a FMH of early onset breast or ovarian cancer 
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had received a mammogram within the past year (data not shown).These study findings may 
be due in part to the challenges of collecting FMH of cancer in the clinical setting. Primary 
care clinicians are often the first healthcare providers to ascertain family health histories and 
refer patients for cancer screening.34 Barriers to collecting the FMH include lack of 
time,18,34 limited tools for use in primary care,34 concerns about validity of self-reported 
FMH,35 and lack of clear guidelines to assist in collecting, interpreting, and using FMH for 
disease risk management.36 Some investigators have indicated that the accuracy of self-
reports of FMH of cancer may be improved if tools rather than interviews are used,34 and if 
information is collected outside of clinical visits, where it could be checked with relatives.35 
The US Surgeon General’s family health history initiative encourages Americans to learn 
more about their family’s health history, and a computerized tool is available to record 
family health information (available at http://www.hhs.gov/familyhistory/). Guidelines on 
how to systematically assess risk of cancer or use the information to guide prevention efforts 
is limited, but some resources are available to providers. The American Medical Association 
provides resources and tools to assist providers in collecting histories (available at http://
www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-
medicine/family-history.page?). As electronic medical records (EMRs) are increasingly 
adopted by primary care physicians, existing tools must be able to interface or be integrated 
into these systems. However, EMRs may allow more extensive FMHs to be assembled more 
easily.37
This study is subject to some limitations. Currently, standardized definitions do not exist for 
moderate and high risk FMH of cancer profiles, so some respondents may have been 
misclassified. CHIS is a cross-sectional telephone survey, so self-reported demographic, 
health behavior, FMH, and cancer screening information may all be subject to social 
desirability bias. FMH of cancer was not verified against medical records or cancer registry 
data, so under- or over-reporting was possible, and this likely occurred with endometrial 
cancer, which is not reported as accurately as other cancer sites.38 Foreign-born status may 
partially explain racial and ethnic differences in reporting FMH of cancer.39 However, 
accurate self-reporting of family history of cancer in first-degree relatives for breast, CRC, 
and prostate cancer is high.38 Our results for California are not generalizable to the overall 
United States population. Because we examined seven different outcomes for several 
different cancer FMH profiles, some findings may be due to chance alone. Despite these 
limitations, few population-based surveys collect data on FMH of cancer that includes age 
of onset and second-degree relatives. CHIS is a large health survey from a racially and 
ethnically diverse population, therefore most of our analyses were not constrained by small 
sample sizes.
Conclusion
Individuals with FMH of breast, ovarian, or CRC cancers are at higher risk of developing 
these same cancers, and would benefit from adopting healthier lifestyles that may reduce 
their own cancer risk. Innovative methods may be needed by California health care 
providers to raise awareness of behavioral risk factors and motivate these individuals to 
adopt healthier lifestyles.
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